Phasebio Pharmaceuticals Inc. Asset Turnover Ratio (PHAS), as of second quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Phasebio Pharmaceuticals Inc.  (NASDAQ: PHAS)
 

Phasebio Pharmaceuticals Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Phasebio Pharmaceuticals's asset turnover ratio, the ratio that measures the ability of Phasebio Pharmaceuticals's assets to generate revenue, sequentially decreased to 0.02 in the second quarter (Jun 30 2022), which does not come as a surprise, as the Phasebio Pharmaceuticals continue to experience difficult business climate.

Within sector 259 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2022 compared to the preceding quarter from 4206 to 4209.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PHAS Asset Turnover Ratio (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Asset Change -78.09 % -61.71 % 21.55 % 34.97 % 43.47 %
Y / Y Revenue Change -97.99 % - - - -
Asset Turnover Ratio (TTM) 0.02 0.16 0.13 0.13 0.13
PHAS's Total Ranking # 4209 # 4206 # 0 # 0 # 0
Seq. Asset Change -42.81 % -36.24 % -22.14 % -22.82 % -0.07 %
Seq. Revenue Change 77.78 % -25.95 % -52.84 % -96.76 % -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 260
Healthcare Sector # 654
Overall Market # 4209

Asset Turnover Ratio Statistics
High Average Low
0.16 0.06 0.02
(Mar 31 2022)   (Jun 30 2022)




PHAS Company Profile • Back to PHAS Efficiency Comparisons • Compare PHAS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2022 Assets at quarter ending Jun 30 2022
Novan Inc   0.10 $ 9.478  Millions$ 92.322  Millions
Vyne Therapeutics Inc   0.10 $ 6.682  Millions$ 66.968  Millions
C4 Therapeutics Inc   0.10 $ 50.066  Millions$ 505.659  Millions
Intelgenx Technologies Corp   0.10 $ 1.722  Millions$ 17.692  Millions
Kymera Therapeutics Inc   0.10 $ 56.747  Millions$ 583.710  Millions
Polarityte Inc   0.09 $ 2.972  Millions$ 32.628  Millions
Lineage Cell Therapeutics Inc   0.09 $ 13.228  Millions$ 146.550  Millions
Eiger Biopharmaceuticals Inc   0.09 $ 13.163  Millions$ 145.925  Millions
Nektar Therapeutics  0.09 $ 96.337  Millions$ 1,070.134  Millions
Aravive Inc   0.09 $ 6.104  Millions$ 68.586  Millions
Statera Biopharma Inc fka Cytocom Inc   0.09 $ 3.254  Millions$ 36.564  Millions
Tarsus Pharmaceuticals Inc   0.09 $ 17.394  Millions$ 200.908  Millions
Nurix Therapeutics Inc   0.09 $ 38.701  Millions$ 450.469  Millions
Rapid Micro Biosystems Inc   0.09 $ 20.127  Millions$ 235.448  Millions
Denali Therapeutics Inc   0.08 $ 112.420  Millions$ 1,366.862  Millions
Titan Pharmaceuticals Inc   0.08 $ 0.741  Millions$ 9.067  Millions
Uniqure N v   0.08 $ 61.969  Millions$ 760.541  Millions
Ideaya Biosciences Inc   0.08 $ 29.148  Millions$ 369.416  Millions
Xenetic Biosciences Inc   0.08 $ 1.488  Millions$ 18.888  Millions
Zymeworks Inc   0.08 $ 31.623  Millions$ 402.109  Millions
Fate Therapeutics Inc   0.08 $ 68.255  Millions$ 892.868  Millions
Zevra Therapeutics Inc   0.08 $ 9.812  Millions$ 130.023  Millions
Hookipa Pharma inc   0.08 $ 11.960  Millions$ 159.035  Millions
Spero Therapeutics Inc   0.08 $ 9.870  Millions$ 131.305  Millions
Sorrento Therapeutics Inc   0.07 $ 54.984  Millions$ 733.844  Millions
Therapeutic Solutions International Inc   0.07 $ 0.225  Millions$ 3.051  Millions
Sigilon Therapeutics Inc   0.07 $ 9.985  Millions$ 135.438  Millions
Pulmatrix Inc   0.07 $ 4.016  Millions$ 54.567  Millions
Gritstone Bio Inc   0.07 $ 18.340  Millions$ 251.703  Millions
Renalytix Plc  0.07 $ 2.970  Millions$ 40.976  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.